ENANTA PHARMACEUTICALS INC
Recent Filings
All 820 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 8-K | 8-K | Mar 26, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 13, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 13, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 13, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 13, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 13, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 13, 2026 |
| 8-K | 8-K | Mar 12, 2026 |
| EFFECT | — | Feb 20, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Capps Kathleen S. | See Remarks | Sale | 323 @ $14.23 | 8,377 | Dec 5, 2025 |
| Trout Harry R. III | See Remarks | Sale | 542 @ $14.23 | 16,348 | Dec 5, 2025 |
| Rottinghaus Scott T. | Chief Medical Officer | Sale | 798 @ $14.23 | 21,792 | Dec 5, 2025 |
| Luu Brendan | Chief Business Officer | Sale | 1,394 @ $14.23 | 38,329 | Dec 5, 2025 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Sale | 2,106 @ $14.23 | 30,620 | Dec 5, 2025 |
| Or Yat Sun | Chief Scientific Officer | Sale | 2,390 @ $14.23 | 371,392 | Dec 5, 2025 |
| Luly Jay R. | President and CEO | Sale | 4,743 @ $14.23 | 858,026 | Dec 5, 2025 |
| Capps Kathleen S. | See Remarks | Award / Grant | 3,163 | 8,992 | Nov 25, 2025 |
| Trout Harry R. III | See Remarks | Award / Grant | 6,463 | 17,375 | Nov 25, 2025 |
| Or Yat Sun | Chief Scientific Officer | Award / Grant | 9,750 | 378,859 | Feb 12, 2025 |